InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TACTILE SYSTEMS TECHNOLOGY INC

TCMD Clue Score67
United States Fiscal year ends December CIK 0001027838 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Laura G. King
3 Nov 2026
Director
Sold on a plan
4,800
$25.00
$120.00K
Kristie Burns
2 Jan 2026
Sr. VP Mktg & Clinical Affairs
Sold on a plan
5,139
$28.85
$148.26K
Elaine M. Birkemeyer
12 May 2025
Chief Financial Officer
Sold on a plan
2,921
$9.94
$29.04K
William W Burke
8 May 2025
Director
Sold on a plan
3,300
$9.67
$31.91K
Daniel L. Reuvers
25 Feb 2025
Director
Sold on a plan
28,338
$14.18
$401.85K
Elaine M. Birkemeyer
25 Feb 2025
Chief Financial Officer
Sold on a plan
2,066
$14.51
$29.98K
Elaine M. Birkemeyer
24 Feb 2025
Chief Financial Officer
Sold on a plan
3,778
$14.70
$55.54K
Daniel L. Reuvers
24 Feb 2025
Director
Sold on a plan
10,938
$14.55
$159.15K
William W Burke
8 May 2024
Director
Sold on a plan
2,500
$14.06
$35.15K
Daniel L. Reuvers
29 Feb 2024
President and CEO
Sold on a plan
1,396
$15.25
$21.29K
Kristie Burns
29 Feb 2024
Sr. VP Mktg & Clinical Affairs
Sold on a plan
243
$15.25
$3.71K
Daniel L. Reuvers
27 Feb 2024
President and CEO
Sold on a plan
4,689
$15.60
$73.15K
Kristie Burns
27 Feb 2024
Sr. VP Mktg & Clinical Affairs
Sold on a plan
1,091
$15.58
$17.00K
Kristie Burns
26 Feb 2024
Sr. VP Mktg & Clinical Affairs
Sold on a plan
2,015
$15.91
$32.05K
Daniel L. Reuvers
26 Feb 2024
President and CEO
Sold on a plan
6,239
$15.81
$98.64K
Kristie Burns
23 Feb 2024
Sr. VP Mktg & Clinical Affairs
Sold on a plan
2,249
$14.80
$33.28K
Daniel L. Reuvers
23 Feb 2024
President and CEO
Sold on a plan
5,378
$14.85
$79.85K
William W Burke
12 May 2023
Director
Sold on a plan
4,400
$21.86
$96.18K
Eric Pauls
8 May 2023
Senior VP, Sales
Sold on a plan
550
$18.55
$10.20K
Kristie Burns
8 May 2023
Sr. VP Mktg & Clinical Affairs
Sold on a plan
786
$18.65
$14.66K
Showing 250 of 394 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 446
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 131
Sales at will 229
Transactions with no price 0
Shares from compensation/vesting 2,801,459
Sales filed before the plan box existed 210
History held since 29 Jul 2016